ORGENESIS
Live / Registered — Registered (as of 26 Mar 2024)
What this means for you
Registered since 26 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90042002
- Registration number
- 7340231
- Mark type
- Stylized text
- Filed
- 08 Jul 2020
- Published for opposition
- 22 Dec 2020
- Registered
- 26 Mar 2024
- Attorney of record
- Jacqueline Zion
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; pharmaceutical products development; pharmaceutical research and development; development of cell therapy products; customization of third-party technologies in the nature of scientific apparatus for processing cells for the manufacture and processing of cells to be used as part of advance cell therapies; development of technologies for the manufacture and processing of cells to be used as part of advance cell therapies
Owner
- Orgenesis Inc., Germantown, MD, US
- Orgenesis Inc., Germantown, MD, US
- Orgenesis Inc., Germantown, MD, US
Prosecution history
- 10 Sept 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 26 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 22 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 21 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 09 Feb 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 05 Feb 2024 — USE AMENDMENT FILED
- 05 Feb 2024 — TEAS STATEMENT OF USE RECEIVED
- 03 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Aug 2023 — SOU EXTENSION 5 GRANTED
- 25 Jul 2023 — SOU EXTENSION 5 FILED
- 02 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 19 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jan 2023 — SOU EXTENSION 4 GRANTED